OZHEALTH PHARMA – Trademark Portfolio
Entity Type: 16
OZHEALTH PHARMA holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DR. SIEGAL'S COOKIE DIET and DR. SIEGAL'S COOKIE DIET SINCE 1975. The owner is based in HURSTVILLE.
40 DONALD STREET
HURSTVILLE 2220 , AU
Showing of trademarks Trademarks
Trademark Classifications
OZHEALTH PHARMA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does OZHEALTH PHARMA have?
OZHEALTH PHARMA has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does OZHEALTH PHARMA file in?
OZHEALTH PHARMA files trademarks across 3 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 44 (Medical Services), Class 30 (Staple Foods). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.
What are OZHEALTH PHARMA's most well-known trademarks?
OZHEALTH PHARMA's registered trademark portfolio includes well-known marks such as DR. SIEGAL'S COOKIE DIET and DR. SIEGAL'S COOKIE DIET SINCE 1975. These are among 2 currently registered trademarks in the portfolio.
What is OZHEALTH PHARMA's trademark registration success rate?
OZHEALTH PHARMA has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.